Drug intelligence / Profile preview

JCI MN COLLOIDAL IODINE

Development stage
Unknown
Lead developer
JCI Colloidal Iodine Laboratory
Modality
Nanoparticles → Drug Delivery Systems, Small Molecules
Administration
Oral, Topical, Intravenous, Ophthalmic, Intranasal
01

Overview

JCI MN COLLOIDAL IODINE is a uniquely formulated colloidal iodine product developed by the JCI Institute of Medical Science. It is designed to deliver bioavailable iodine in a colloidal form, which increases absorption and reduces toxicity compared to elemental or compound forms of iodine. The formulation allows for various routes of administration, including oral ingestion, topical application, and intravenous infusion. Its primary mechanisms include direct viricidal and antibacterial activity, modulation of immune responses (such as inhibition of T cell proliferation and cytokine production), anti-inflammatory effects via inhibition of IL4 and TNFα activation in fibroblasts, restoration of mitochondrial function, improvement in tissue metabolism, anti-allergy effects, and biomodulation within the tumor microenvironment. It has been studied for use against viral infections (including COVID-19), ophthalmic disorders (as an eye wash), intraoral diseases (mouth rinse or toothpaste), intranasal conditions (nasal drops), inflammatory diseases, cancer treatment as part of multidisciplinary regimens with chemotherapy/thermotherapy/hyperbaric oxygen therapy, respiratory conditions like asthma, neurological disorders, arteriosclerotic disease, thyroid-related conditions due to its role as an essential micronutrient for thyroid hormone synthesis[1][2][3][5].

Brand names
JCI MN COLLOIDAL IODINEJCI MN COLLOIDAL IODINE IMMUNE-IMPROVING WATERJCI MN COLLOIDAL IODINE EYE WASH CLEANSING WATER
Other names
colloidal iodine (as a general term)iodine solution (as labeled)
02

Targets

IL4R (Interleukin-4 receptor alpha subunit)

Beyond the preview

Go deeper on JCI MN COLLOIDAL IODINE.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on JCI MN COLLOIDAL IODINE.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call